
On June 11, 2026, Sun Pharmaceutical Industries Limited announced the schedule for its 34th Annual General Meeting (AGM) and details regarding the final dividend for the financial year 2025-26.
The AGM is set for July 31, 2026, and the record date for the dividend is July 7, 2026.
The 34th AGM of Sun Pharmaceutical Industries is scheduled for July 31, 2026, at 4:00 p.m. (IST). The meeting will be conducted through video conferencing, ensuring compliance with statutory requirements.
Shareholders are advised to update their contact details with their Depository Participants or the Company's Registrar and Transfer Agent to receive timely communications.
Sun Pharmaceutical Industries has fixed July 7, 2026, as the record date for determining shareholder entitlement to the final dividend.
The proposed dividend is ₹5 per equity share for the financial year 2025-26. If approved at the AGM, the dividend will be paid on or before August 7, 2026.
Read More: Ajanta Pharma and Emcure Pharmaceuticals Share Price Gain After Kotak Mahindra Mutual Fund Buys Stakes!
The final dividend will be subject to tax deduction at source (TDS) at applicable rates. Shareholders are encouraged to review the TDS guidance available on the company's website and submit requisite documents by July 7, 2026, to ensure the correct TDS rate is applied.
For any queries, shareholders can contact Sun Pharmaceutical Industries at their registered office in Mumbai or Vadodara. The company can also be reached via email at secretarial@sunpharma.com or through their website www.sunpharma.com.
As of June 12, 2026, at 12:55 PM, Sun Pharmaceutical Industries share price on NSE was trading at ₹1,809.30 up by 0.84% from the previous closing price.
Sun Pharmaceutical Industries has scheduled its 34th AGM for July 31, 2026, and set July 7, 2026, as the record date for a final dividend of ₹5 per share. The dividend payment, subject to AGM approval, is expected by August 7, 2026.
Read stock market news in Hindi. Head to Angel One's share market news in Hindi for comprehensive coverage.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Jun 12, 2026, 2:35 PM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
